Skip to main content
logo
ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.155
+0.005 (0.43%)
Nov 6, 2026, 4:00 PM EST - Market closed

ALX Oncology Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-82.79-100.85-142.47-170.28-127.44-83.56
Net Income
-80.89-101.7-134.85-160.81-123.48-83.46
Earnings Per Share
-0.93-1.90-2.58-3.74-3.03-2.07
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
138.2344.79127.76182.74266.21363.67
Total Debt
11.0414.779.99.649.390.74
Net Cash (Debt)
127.1930.02117.85173.1256.82362.93
Net Cash Growth
101.47%-74.53%-31.91%-32.60%-29.24%-16.42%
Net Cash Per Share
1.470.562.264.036.319.00

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-70.78-84.14-121.91-130.36-89.22-68.1
Capital Expenditures
-0.17-0.21-0.45-1.27-1.43-0.67
Free Cash Flow
-70.95-84.35-122.36-131.64-90.65-68.77
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------